Schedule 13D ownership disclosure
Salarius Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 79400X107
Event date: 2019-07-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.2700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-205632
- Form type
- SC 13D
- Filer
- Salarius Pharmaceuticals, Inc.
- CIK
- CIK 1615219
- Filed
- Jul 29, 2019
- Reporting period
- Jul 19, 2019
- Description
- Schedule 13D beneficial ownership